| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/27/2006 | US7067309 Used for the transfer and expression of exogenous nucleotide sequences in a host cell or organism; gene therapy |
| 06/27/2006 | US7067301 Comprises nucleotide sequences coding prothrombin enzyme for diagnosis, treatment and prevention of nervous system, liver, blood and cancer disorders; wound healing agents |
| 06/27/2006 | US7067297 Mannosyltransferase polypeptides and polynucleotides encoding them and methods for making and using them |
| 06/27/2006 | US7067282 Compositions and methods using the yeast YLR110C promoter |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |
| 06/27/2006 | US7067280 Human cartilage glycoprotein |
| 06/27/2006 | US7067278 capable of hybridizing and which encodes a pigment protein capable of emitting fluorescence upon irradiation; tissue marker, fluorescent marker or general dyestuff |
| 06/27/2006 | US7067277 Chimeric G proteins and uses thereof |
| 06/27/2006 | US7067274 Compositions and methods for the screening pro-apoptotic compounds |
| 06/27/2006 | US7067265 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 06/27/2006 | US7067262 Determination binding of gabapentin to cells |
| 06/27/2006 | US7067260 Detecting modulators of receptor binding activity; obtain sample containing receptor protein, incubate with modulator, monitor and evaluate protein binding |
| 06/27/2006 | US7067259 Multidrug resistance proteins in Drosophila and Anopheles |
| 06/27/2006 | US7067255 Hereditary hemochromatosis gene |
| 06/27/2006 | US7067249 with stably expressed short hairpin rnas which degrade hbv pregenomic rna and mRNA; for treatment of cancer, hormonal therapy, immunotherapy, and radiation therapy |
| 06/27/2006 | US7067247 Comprises mutant hepatitis B surface antigen for detecting viral diseases; immunoassays; kidney disorders |
| 06/27/2006 | US7067135 RAP (RNAIII activating protein) polypeptide of amino acid sequence 13 |
| 06/27/2006 | US7067133 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier |
| 06/27/2006 | US7067132 Binding to muteins; prevent signal transduction; monoclonal antibodies; graft versus host disease; antiarthritic agents; antidiabetic agents; skin disorders; autoimmune disease; inflammatory bowel disorders; anticancer agents |
| 06/27/2006 | US7067130 Genetic engineering; polypeptide; cancer diagnosis |
| 06/27/2006 | US7067126 Synthase enzymes having chemokine, angiogenic or angiostsatic activity, used for medical diagnosis and prognosis |
| 06/27/2006 | US7067125 Lantibiotic polypeptides; useful as antimicrobials in antibiotic pharmaceutical preparation and as antimicrobial or antiseptic dentifrice |
| 06/27/2006 | US7067118 Methods of using mutant flt3-ligand polypeptides to induce cellular expansion |
| 06/27/2006 | US7067117 Compounds and methods to inhibit or augment an inflammatory response |
| 06/27/2006 | US7067112 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline |
| 06/27/2006 | CA2283740C Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 06/27/2006 | CA2237224C Synthetic hpv11 virus-like particles |
| 06/27/2006 | CA2124034C Gene coding for a protein regulating aureobasidin sensitivity |
| 06/22/2006 | WO2006066258A2 Lipoconjugation of peptides |
| 06/22/2006 | WO2006066224A2 Virulence targeted antibiotics |
| 06/22/2006 | WO2006066089A1 Humanized amyloid beta antibodies for use in improving cognition |
| 06/22/2006 | WO2006066065A2 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv |
| 06/22/2006 | WO2006066064A2 A voltage-gated, ph-sensitive anion channel and its novel splice variant involved in taste sensation |
| 06/22/2006 | WO2006066024A2 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 06/22/2006 | WO2006065981A2 Nucleic acid molecules for optimized cab-2 expression and their use |
| 06/22/2006 | WO2006065867A2 Polymer-linked pseudomonas exotoxin immunotoxin |
| 06/22/2006 | WO2006065851A1 Biopolymer including prolamin and methods of making it |
| 06/22/2006 | WO2006065821A2 Improved dna immunization with recombinase/transposase |
| 06/22/2006 | WO2006065582A2 Muteins of fibroblast growth factor 21 |
| 06/22/2006 | WO2006065166A1 Protein l1 and protein e7 peptide-based composition for treating and preventing a human papillomaviral infection |
| 06/22/2006 | WO2006064639A1 Titanium-binding ferritin and method of arraying inorganic particle |
| 06/22/2006 | WO2006064378A2 Adjuvant activity of gastrointestinal peptides |
| 06/22/2006 | WO2006064376A1 Peptides for treating retrovirus infection |
| 06/22/2006 | WO2006064176A1 Assays for superantigens |
| 06/22/2006 | WO2006064133A2 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 06/22/2006 | WO2006064072A1 Peptides, nucleotide sequences and cnalinker13 cells and applications thereof |
| 06/22/2006 | WO2006063844A1 Soluble hla-e molecules and their use for diagnosing and treating pathologies |
| 06/22/2006 | WO2006063567A1 Method for determining inflammatory processes, and pharmaceutical compositions for the treatment thereof |
| 06/22/2006 | WO2006063518A1 Multifunctional polypeptides |
| 06/22/2006 | WO2006063425A1 Expression vectors for treating bacterial infections |
| 06/22/2006 | WO2006063390A1 Osteoprotegerin variant proteins |
| 06/22/2006 | WO2006061414A1 Methods and agents useful in treating conditions characterized by mucus hyperproduction/ hypersecretion |
| 06/22/2006 | WO2006048757A3 Anti-bacterial vaccine compositions |
| 06/22/2006 | WO2006041917A3 An insecticidal plant cyclotide with activity against homopteran insects |
| 06/22/2006 | WO2006040047A3 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 06/22/2006 | WO2006038129A3 Hepatitis c virus replication system |
| 06/22/2006 | WO2006034832A3 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions |
| 06/22/2006 | WO2006034232A3 Diagnostic marker |
| 06/22/2006 | WO2006034106A9 Baff variants and methods therof |
| 06/22/2006 | WO2006029719A3 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 1, group h, member 4 (nr1h4) |
| 06/22/2006 | WO2006027701A3 Fas associated factor 1 |
| 06/22/2006 | WO2006027699A3 Rnaiii-inhibiting peptides for treating hiv infection |
| 06/22/2006 | WO2006021453A3 Optimized nucleotide sequences encoding sgp 130 |
| 06/22/2006 | WO2006014678A3 Compositions and methods of using angiopoietin-like 4 protein |
| 06/22/2006 | WO2006012415A3 Rage protein derivatives |
| 06/22/2006 | WO2006008008A3 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| 06/22/2006 | WO2005118636A3 Tgf derepressors and uses related thereto |
| 06/22/2006 | WO2005118633A3 Electrical conductors and devices from prion-like proteins |
| 06/22/2006 | WO2005115130A3 Transgenic ficus, method for producing same and use thereof |
| 06/22/2006 | WO2005105832A3 Biologically active peptide vapeehptllteaplnpk derivatives |
| 06/22/2006 | WO2005105138A3 Collagen mimics |
| 06/22/2006 | WO2005101004A8 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 06/22/2006 | WO2005091751A3 Novel gene associated with type 1 diabetes and methods of use |
| 06/22/2006 | WO2005089101A3 Non-pathogenic listeria vaccine vectors and methods of treatment therewith |
| 06/22/2006 | WO2005085867A8 Screening method for emulators of neural activity and digestive system using gpr35 |
| 06/22/2006 | WO2005033343A8 Novel splice variants of human dkkl1 |
| 06/22/2006 | WO2005028665A3 Campylobacter polypeptides and methods of use |
| 06/22/2006 | WO2005010030A3 C5a receptor antagonists |
| 06/22/2006 | WO2005001051A3 Compositions and methods for regulating polysaccharides of a plant cell |
| 06/22/2006 | WO2004052276A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/22/2006 | WO2003102130A3 A human cell assay to determine effect of sample compounds on col2 enhancer expression |
| 06/22/2006 | WO2003004617A3 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 06/22/2006 | US20060137043 metabolic activity is altered by transformation with a Stress-Related Protein (SRP) coding nucleic acid |
| 06/22/2006 | US20060137041 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
| 06/22/2006 | US20060137029 Novel G protein-coupled receptor encoding gene and diagnostic uses therefor |
| 06/22/2006 | US20060136146 Modulators of ribosomal function and identification thereof |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135757 DNA sequence in plant Caragana jubata with freeze tolerance |
| 06/22/2006 | US20060135756 Mammalian cell surface antigens; related reagents |
| 06/22/2006 | US20060135754 Novel carbamylated EPO and method for its production |
| 06/22/2006 | US20060135753 Modified hemoglobin and methods of making same |
| 06/22/2006 | US20060135752 Method of obtaining biologically active collagen from skins of the salmonidae fish |
| 06/22/2006 | US20060135751 Human N-type calcium channel isoform and uses thereof |
| 06/22/2006 | US20060135750 Novel protein and gene encoding the same |
| 06/22/2006 | US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 06/22/2006 | US20060135748 excellent antimicrobial activity under strong acidic and basic environments, it also shows strong antimicrobial activity against resistant bacteria., it can be used usefully as a natural antimicrobial agent |
| 06/22/2006 | US20060135747 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 06/22/2006 | US20060135746 Peptide used to inhibit the binding of HIV to cell surface receptor CD4 |
| 06/22/2006 | US20060135451 Vaccine |
| 06/22/2006 | US20060135449 A NF- kappa B decoy oligodeoxynucleotide of the sequence GGATTTCCC delivered in a liposome through the carotid artery; antiischemic agents, antitumor agents; analgesics, Alzheimer's Disease; gene transfection |